United States & Jay Bhattacharya

United States: The United States repatriated and quarantined its citizens exposed on the MV Hondius, with the CDC officially ending its hantavirus response. Researchers in the United States are also working on hantavirus treatments and vaccines.

Jay Bhattacharya: As acting Director of the CDC, Jay Bhattacharya commented on the strength of the coordinated response to infectious disease threats.

United States: The United States is the primary market for the mFlusiva vaccine, with tens of thousands of Americans dying from influenza annually. The approval of this mRNA vaccine could significantly impact public health strategies and pandemic preparedness within the country.

Jay Bhattacharya: Jay Bhattacharya is the acting director of the United States — Centers for Disease Control and Prevention (CDC), and will ultimately decide whether to adopt, change, or reject the advisory committee's recommendation for the vaccine.

Jay Bhattacharya: Jay Bhattacharya, National Institutes of Health Director, announced a $50 million investment in autism research projects.

Jay Bhattacharya: Jay Bhattacharya, director of the United States — National Institutes of Health, stated during a Senate hearing that no single vaccine causes autism, providing a scientific perspective amidst the ongoing debate.

Jay Bhattacharya: Jay Bhattacharya, the United States — National Institutes of Health Director, has been overseeing the United States — Centers for Disease Control and Prevention since February, and his public statements during the hantavirus outbreak contained inaccuracies.